ARCHIVES

Howard Temin, 59, NCAB Member, Nobel Laureate, Dead

This article is from The Cancer Letter archive.

Vol. 20 No. 07 | February 18, 1994

Download PDF Visit The Full Archive

Related Articles

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

NIH Accepting FIRST Applications

May 2, 1986

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013

Outside Experts Might Lengthen NDA Approval, Peck Asserts

September 7, 1990

In Brief: House Committee Approves Funding Boost For NIH; Michigan Centers Receive $15M Gift

July 28, 1995

NCAB Removes Its Restrictions On PDQ Access, Permits NCI Staff To Decide

February 7, 1986